|
Phenotypic Information (metabolism pathway, cancer, disease, phenome) | |
Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG | |
Gene Summary for PHGDH |
Basic gene info. | Gene symbol | PHGDH |
Gene name | phosphoglycerate dehydrogenase | |
Synonyms | 3-PGDH|3PGDH|HEL-S-113|NLS|NLS1|PDG|PGAD|PGD|PGDH|PHGDHD|SERA | |
Cytomap | UCSC genome browser: 1p12 | |
Genomic location | chr1 :120254418-120286849 | |
Type of gene | protein-coding | |
RefGenes | NM_006623.3, | |
Ensembl id | ENSG00000092621 | |
Description | 3-phosphoglycerate dehydrogenaseD-3-phosphoglycerate dehydrogenaseepididymis secretory protein Li 113 | |
Modification date | 20141211 | |
dbXrefs | MIM : 606879 | |
HGNC : HGNC | ||
Ensembl : ENSG00000092621 | ||
HPRD : 06047 | ||
Vega : OTTHUMG00000012100 | ||
Protein | UniProt: O43175 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_PHGDH | |
BioGPS: 26227 | ||
Gene Expression Atlas: ENSG00000092621 | ||
The Human Protein Atlas: ENSG00000092621 | ||
Pathway | NCI Pathway Interaction Database: PHGDH | |
KEGG: PHGDH | ||
REACTOME: PHGDH | ||
ConsensusPathDB | ||
Pathway Commons: PHGDH | ||
Metabolism | MetaCyc: PHGDH | |
HUMANCyc: PHGDH | ||
Regulation | Ensembl's Regulation: ENSG00000092621 | |
miRBase: chr1 :120,254,418-120,286,849 | ||
TargetScan: NM_006623 | ||
cisRED: ENSG00000092621 | ||
Context | iHOP: PHGDH | |
cancer metabolism search in PubMed: PHGDH | ||
UCL Cancer Institute: PHGDH | ||
Assigned class in ccmGDB | A - This gene has a literature evidence and it belongs to cancer gene. | |
References showing role of PHGDH in cancer cell metabolism | 1. Mullarky E, Mattaini KR, Vander Heiden MG, Cantley LC, Locasale JW (2011) PHGDH amplification and altered glucose metabolism in human melanoma. Pigment cell & melanoma research 24: 1112-1115. go to article 2. Kim HM, Jung WH, Koo JS (2014) Site-specific metabolic phenotypes in metastatic breast cancer. Journal of translational medicine 12: 1-17. go to article 3. Mattaini KR, Brignole EJ, Kini M, Davidson SM, Fiske BP, et al. (2015) An epitope tag alters phosphoglycerate dehydrogenase structure and impairs ability to support cell proliferation. Cancer Metab 3: 5. doi: 10.1186/s40170-015-0131-7. pmid: 4414297. go to article 4. Ou Y, Wang SJ, Jiang L, Zheng B, Gu W (2015) p53 Protein-mediated regulation of phosphoglycerate dehydrogenase (PHGDH) is crucial for the apoptotic response upon serine starvation. J Biol Chem 290: 457-466. doi: 10.1074/jbc.M114.616359. pmid: 4281747. go to article 5. Kim SK, Jung WH, Koo JS (2014) Differential expression of enzymes associated with serine/glycine metabolism in different breast cancer subtypes. PLoS One 9: e101004. doi: 10.1371/journal.pone.0101004. pmid: 4076239. go to article 6. Chen J, Chung F, Yang G, Pu M, Gao H, et al. (2013) Phosphoglycerate dehydrogenase is dispensable for breast tumor maintenance and growth. Oncotarget 4: 2502-2511. pmid: 3926844. go to article 7. Ma L, Tao Y, Duran A, Llado V, Galvez A, et al. (2013) Control of nutrient stress-induced metabolic reprogramming by PKCzeta in tumorigenesis. Cell 152: 599-611. doi: 10.1016/j.cell.2012.12.028. pmid: 3963830. go to article |
Top |
Phenotypic Information for PHGDH(metabolism pathway, cancer, disease, phenome) |
Cancer Description | |
Cancer | CGAP: PHGDH |
Familial Cancer Database: PHGDH |
* This gene is included in those cancer gene databases. |
. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Oncogene 1 | Significant driver gene in |
cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
Metabolic Pathway Description | |
KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES |
Others | |
OMIM | 256520; phenotype. 601815; phenotype. 606879; gene. |
Orphanet | 2671; Neu-Laxova syndrome. 79351; 3-phosphoglycerate dehydrogenase deficiency. |
Disease | KEGG Disease: PHGDH |
MedGen: PHGDH (Human Medical Genetics with Condition) | |
ClinVar: PHGDH | |
Phenotype | MGI: PHGDH (International Mouse Phenotyping Consortium) |
PhenomicDB: PHGDH |
Mutations for PHGDH |
* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
Structural Variants in COSMIC: go to COSMIC mutation histogram |
There's no structural variation information in COSMIC data for this gene. |
Related fusion transcripts : go to Chitars2.0 |
* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows PHGDH related fusion information. |
ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
BF804555 | PHGDH | 11 | 147 | 1 | 120284422 | 120285464 | PHGDH | 137 | 214 | 1 | 120285552 | 120285630 | |
BE844016 | HLA-DRA | 15 | 189 | 6 | 3759098 | 3759271 | PHGDH | 184 | 239 | 1 | 120286659 | 120286714 | |
AW261826 | PHGDH | 19 | 400 | 1 | 120285616 | 120286838 | EPHX1 | 395 | 553 | 1 | 226016559 | 226019583 | |
BC004528 | PHGDH | 49 | 889 | 1 | 120254576 | 120278045 | UBAC2 | 887 | 2734 | 13 | 99896770 | 100038682 |
Other DBs for Structural Variants |
Top |
Copy Number Variations in COSMIC: go to COSMIC mutation CNV/Expr |
Mutation type/ Tissue ID | brca | cns | cerv | endome | haematopo | kidn | Lintest | liver | lung | ns | ovary | pancre | prost | skin | stoma | thyro | urina | |||
Total # sample |   |   |   |   |   |   |   |   | 1 |   | 1 |   |   | 2 | 2 |   |   | |||
GAIN (# sample) |   |   |   |   |   |   |   |   | 1 |   | 1 |   |   | 2 | 2 |   |   | |||
LOSS (# sample) |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
cf) Tissue ID; Tissue type (1; Breast, 2; Central_nervous_system, 3; Cervix, 4; Endometrium, 5; Haematopoietic_and_lymphoid_tissue, 6; Kidney, 7; Large_intestine, 8; Liver, 9; Lung, 10; NS, 11; Ovary, 12; Pancreas, 13; Prostate, 14; Skin, 15; Stomach, 16; Thyroid, 17; Urinary_tract) |
Top |
SNV Counts per Each Loci in COSMIC data: go to COSMIC point mutation |
|
Top |
Somatic Mutation Counts per Tissue in COSMIC data |
Stat. for Non-Synonymous SNVs (# total SNVs=35) | (# total SNVs=12) |
(# total SNVs=1) | (# total SNVs=0) |
Top |
Top 10 SNVs Having the Most Samples in COSMIC data |
* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
GRCh37 position | Mutation(aa) | Unique sampleID count |
chr1:120263849-120263849 | p.N65N | 4 |
chr1:120284428-120284428 | p.A373T | 3 |
chr1:120285546-120285546 | p.T442T | 3 |
chr1:120279735-120279735 | p.? | 2 |
chr1:120277917-120277917 | p.? | 2 |
chr1:120269623-120269623 | p.? | 2 |
chr1:120263923-120263923 | p.R90K | 2 |
chr1:120254648-120254648 | p.M1I | 2 |
chr1:120279853-120279853 | p.F303F | 2 |
chr1:120283043-120283043 | p.P327L | 2 |
Top |
SNV Counts per Each Loci in TCGA data |
|
Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
# sample | 1 |   |   | 5 | 1 |   |   |   | 2 |   |   | 8 | 2 | 1 |   |   | 4 | 2 | 1 | 11 |
# mutation | 1 |   |   | 5 | 1 |   |   |   | 2 |   |   | 8 | 2 | 1 |   |   | 4 | 2 | 1 | 11 |
nonsynonymous SNV |   |   |   | 3 | 1 |   |   |   | 2 |   |   | 6 | 2 |   |   |   | 2 | 2 | 1 | 5 |
synonymous SNV | 1 |   |   | 2 |   |   |   |   |   |   |   | 2 |   | 1 |   |   | 2 |   |   | 6 |
cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
Top |
Top 10 SNVs Having the Most Samples in TCGA data |
* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
Genomic Position | Mutation(aa) | Unique sampleID count |
chr1:120279853 | p.F303F | 2 |
chr1:120284439 | p.R119M | 1 |
chr1:120263907 | p.R294H | 1 |
chr1:120277939 | p.P122P | 1 |
chr1:120284452 | p.C295Y | 1 |
chr1:120263915 | p.A124V | 1 |
chr1:120277957 | p.R135Q | 1 |
chr1:120284473 | p.V376V | 1 |
chr1:120266064 | p.R163Q | 1 |
chr1:120277960 | p.E381Q | 1 |
Other DBs for Point Mutations |
Copy Number for PHGDH in TCGA |
* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
Top |
Gene Expression for PHGDH |
Gene Expression in Cancer Cell-lines (CCLE) |
* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
Differential Gene Expression in Primary Tumors (TCGA) |
* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
Top |
CNV vs Gene Expression Plot |
* This plots show the correlation between CNV and gene expression. |
Top |
Gene-Gene Network Information |
Co-Expressed gene's network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
AMBN,ATP1A1,BPI,CMC2,CNTN6,FRZB,FTMT, KCNJ16,MDGA2,NCALD,NECAB2,NOTCH2,PHGDH,PLSCR5, ROPN1B,SEC22B,SLC39A12,SLC43A3,SPON1,WARS2,ZNF697 | ACAD9,FAHD2A,HOOK2,HYI,KLHL22,LPHN1,LRP5, MDFI,MESP1,PHGDH,PPP1R1B,SCRN2,SELENBP1,SF3B2, SLC19A1,SLC25A10,SLC25A6,THRA,TYSND1,VPS26B,WIPI2 | ||||
AARS,ASNS,ATF4,CARS,CBS,GARS,GPT2, MARS,MTHFD2,PHGDH,PSAT1,SARS,SHMT2,SLC3A2, SLC4A5,SLC7A5,STC2,TARS,ULBP1,XPOT,YARS | ABCC9,ACTA2,ANXA6,AOC3,ATP1A2,CLIP3,CNGA3, CPXM2,FBXL22,FHL3,HRASLS5,LOXL4,MAGEE1,NIPAL4, NLGN1,NPTXR,PDE2A,PHGDH,SLIT2,TGFB1I1,TMEM200B |
Co-Expressed gene's Protein-protein interaction Network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
Top |
Interacting Genes (from Pathway Commons) |
Top |
Pharmacological Information for PHGDH |
Cross-referenced pharmacological DB IDs from Uniprot |
DB Category | DB Name | DB's ID and Url link |
Chemistry | ChEMBL | CHEMBL2311243; -. |
Organism-specific databases | PharmGKB | PA33264; -. |
Organism-specific databases | CTD | 26227; -. |
Drug-Gene Interaction Network |
* Gene Centered Interaction Network. |
* Drug Centered Interaction Network. |
DrugBank ID | Target Name | Drug Groups | Generic Name | Drug Centered Network | Drug Structure |
DB00157 | phosphoglycerate dehydrogenase | approved; nutraceutical | NADH | ||
DB01907 | phosphoglycerate dehydrogenase | experimental | Nicotinamide-Adenine-Dinucleotide | ||
DB01694 | phosphoglycerate dehydrogenase | experimental | D-tartaric acid |
Top |
Cross referenced IDs for PHGDH |
* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |